Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotoxin therapy

W A Hall1

  • 1Department of Neurosurgery, University of Minnesota Hospital and Clinic, Minneapolis, USA.

Neurosurgery Clinics of North America
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Immunotoxins effectively target metastatic tumor cells by inhibiting protein synthesis, showing promise in preclinical and early clinical studies for brain metastases and radioresistant tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Liver Metastases Treated With Magnetic Resonance Imaging Guided Stereotactic Body Radiation Therapy: Outcomes of Tolerability, Acute Toxicity, and Quality of Life From the MOMENTUM Study.

Practical radiation oncology·2025
Same author

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.

medRxiv : the preprint server for health sciences·2024
Same author

Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study.

Clinical and translational radiation oncology·2024
Same author

Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer.

Practical radiation oncology·2017
Same journal

Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Spinal Cord Deformities Associated with Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Radiation Therapy for Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Treatment Strategies of Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Vascular Lesions of the Spinal Cord: Arteriovenous and Cavernous Malformations.

Neurosurgery clinics of North America·2026
Same journal

Hemangioblastomas of the Spinal Cord.

Neurosurgery clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Immunotoxins are potent agents targeting specific antigens on metastatic tumor cells.
  • They induce cytotoxicity by inhibiting protein synthesis post-cell entry.
  • Demonstrated in vitro efficacy against various metastatic tumor cell lines.

Purpose of the Study:

  • To evaluate the efficacy of immunotoxins in preclinical and clinical settings.
  • To assess their potential for treating brain metastases and radioresistant tumors.

Main Methods:

  • In vitro studies on metastatic tumor cell lines.
  • In vivo studies in athymic animal models with flank tumors or leptomeningeal neoplasia.
  • Phase I clinical trials in patients with carcinomatous meningitis or intraparenchymal brain metastases.

Related Experiment Videos

Main Results:

  • Complete tumor regression observed in animal models.
  • Therapeutic efficacy demonstrated in human patients with brain metastases.
  • Immunotoxins show potential for widespread intracranial metastatic disease.

Conclusions:

  • Immunotoxins exhibit significant preclinical and clinical efficacy.
  • They are a promising therapeutic option for patients with brain metastases.
  • Considered particularly appropriate for widespread intracranial disease or radioresistant histologies.